Novo Nordisk Inhaled Insulin To Resume Phase III Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
Trials for the AERx inhaled insulin system will involve both type 1 and type 2 diabetes, despite a previous safety signal in type 1 patients.